Vascular endothelial growth factor, p53, and the H-ras oncogene in Egyptian patients with bladder cancer

Table 5 Kaplan-Meier estimates of 3-year disease-free survival in relation to patient and tumour characteristics in the transitional cell carcinoma group

Characteristic	n	3-year survival rate (%)	P value
Total No.	50	68.0
Age (yr)
≤ 50	11	71.8	0.487
> 50	39	54.5
Sex
Male	42	64.3	0.126
Female	8	87.5
Grade
G2	18	72.2	0.128
G3	32	65.6
Stage
pT1	8	100	0.601
pT2	28	71.4
pT3	7	57.1
pT4	7	28.6
Node status
Positive	6	16.7	0.008
Negative	44	75.0
p53
Positive	33	63.6	0.962
Negative	17	76.5
VEGF
Positive	17	64.7	0.791
Negative	33	69.7
H-ras
Positive	8	66.7	0.967
Negative	42	75.0